BBIO
BridgeBio Pharma, Inc.Company with tickers: BBIO
CIK
1743881
CUSIP
10806X102
Shares Outstanding
195,861,242
13F Activity (30d)
253 filings
248 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2025-06-23 | 2025-06-20 | |
| 8-K | 2025-07-02 | 2025-06-27 | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-10-27 | — | |
| 8-K | 2025-10-29 | — | |
| 10-Q | 2025-10-29 | 2025-09-30 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-21 | 2026-01-14 | |
| 8-K | 2026-02-12 | — | |
| 10-K | 2026-02-24 | 2025-12-31 | |
| 8-K | 2026-02-24 | — | |
| 8-K | 2026-03-30 | — | |
| 8-K | 2026-05-07 | 2026-05-06 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-08 | 2026-05-07 | |
| 8-K | 2026-05-13 | 2026-05-12 | |
| 8-K | 2026-05-27 | — |
Showing 101–118 of 118 filings